The Latest Breaking News from DRI

70% increase in narcotics consumption in past 8 years: Hyderabad CP

Two foreign nationals were carrying 8 kg of contraband

Credit Suisse analyst Lauren Silberman lowered the price target on Darden Restaurants Inc (NYSE:DRI) from $180 to $175 and maintained Outperform rating on the shares. The revised price target implies a 34% upside. While the analyst acknowledged the concerns about the discretionary nature of casual dining, she believes Darden is well-positioned to wade through near-term…

Darden Restaurants (NYSE:DRI) has outperformed the market over the past 20 years by 1.53% on an annualized basis producing an average annual return of 8.62%. Currently, Darden Restaurants has a market capitalization of $17.00 billion.

Darden Restaurants Inc (NYSE:DRI) reported third-quarter FY22 sales growth of 41.3% year-on-year, to $2.45 billion, missing the consensus of $2.51 billion. Same-restaurant sales increased 38.1%. Darden clocked an operating margin of 12.3%, and the operating income jumped 103.4% Y/Y to $301 million. EBITDA was $395 million. EPS of $1.93 missed the consensus of…

The package was slated to be shipped to Saudi Arabia and was booked by a person from Tamil Nadu with a fake name and address of the sender

Despite strong demand for its products, rising input costs, supply chain bottlenecks, and labor shortages have caused prominent coffee chain Starbucks (SBUX) to miss analysts’ estimates in its last reported quarter. And bcause SBUX could continue raising prices to offset its rising input costs, many analysts are worried about the…

The FDA approved CTI BioPharma Corp's (NASDAQ:CTIC) Vonjo (pacritinib) for treating adult patients with myelofibrosis, a type of bone marrow cancer with low blood platelets count. Pacritinib is a JAK inhibitor and will compete with Incyte Corporation's (NASDAQ:INCY) Jakafi and Bristol Myers Squibb's Co (NYSE:BMY) Inrebic, which were approved in 2011 and 2019, respectively for myelofibrosis. CTI…

If history is any guide, there may be trouble ahead for shares of Darden Restaurants (NYSE:DRI). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.